Cookies on Pinsent Masons website

This website uses cookies to allow us to see how the site is used. The cookies cannot identify you. If you continue to use this site we will assume that you are happy with this

If you want to use the sites without cookies or would like to know more, you can do that here.

Plans to extend patent infringement exemption for drugs testing approved

A UK parliamentary committee has given its backing to proposed new laws which would allow organisations to conduct clinical drugs testing without infringing others' patent rights. 24 Jun 2014

UK dementia treatment review to focus on patents, funding and getting new drugs to patients earlier

A major programme of work aimed at addressing the "achingly slow" progress of research into and development of treatments for dementia is to get underway in the UK, the prime minister has announced. 19 Jun 2014

Out-Law Guides

Clinical trial data to be available for download for academic and non-commercial purposes

Clinical trial data submitted as part of marketing authorisation applications in the European Union will be available for downloading, saving and printing for academic and non-commercial research purposes, the European Medicines Agency (EMA) has said. 19 Jun 2014

EIB to provide up to €75 million funding to Belgian pharmaceutical company in first deal of new InnovFin initiative

The European Investment Bank (EIB) is to provide Belgian pharmaceutical company UCB with up to €75 million of "at risk co-development funding" for the development of selected UCB products, the bank has announced. 17 Jun 2014

More stories

Join My Out-Law

  • See only the content that matters to you
  • Tailor Out-Law to your exact needs
  • Save the most useful content for later reading
  • Tailor our weekly eNewsletter to your interests

Join My Out-Law

Already signed up to My Out-Law? Sign in

Expertise in Patents

Whether you are looking for advice on patent protection for your inventions, licensing technology to others to maximise value, licensing technology for your own use, considering patent litigation - or somewhere in between - our large international patents team can help.

More about Patents